Cadrenal Therapeutics (NasdaqCM:CVKD) 2025 Conference September 30, 2025 03:30 PM ET Company ParticipantsTerry Ferguson - Chief Medical OfficerModeratorAll right, hello everyone. Thank you so much for joining us throughout the day here at the Lytham Partners Fall 2025 Investor Conference. Again, my name is Robert Blum, Managing Partner here at Lytham Partners. Coming up next, we have a presentation from Cadrenal Therapeutics, company trades under the ticker symbol CVKD on the NASDAQ. Presenting from the com ...